Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Cotinine

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    62 result(s) found for: Cotinine. Displaying page 1 of 4.
    1  2  3  4  Next»
    EudraCT Number: 2006-001099-20 Sponsor Protocol Number: CPR-EFC5515-EN-E02 Start Date*: 2006-05-18
    Sponsor Name:sanofi-aventis recherche & développement
    Full Title: An international, seven-week, double blind, placebo-controlled, two parallel group study to assess the efficacy of dianicline 40 mg bid as an aid to smoking cessation in cigarette smokers
    Medical condition: Cigarette smokers willing to quit
    Disease: Version SOC Term Classification Code Term Level
    8.1 10057852 Nicotine dependence LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed) NO (Completed) DK (Completed) BE (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2005-000922-22 Sponsor Protocol Number: TA-NIC/03 Start Date*: 2006-04-18
    Sponsor Name:Xenova Ltd
    Full Title: A phase II double blind, randomised, placebo controlled, multicentre study to assess the efficacy and safety of TA-NIC in maintaining smoking cessation when given in conjunction with Nicotine Repla...
    Medical condition: Prevention of relapse in smokers who have quit.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2006-005334-21 Sponsor Protocol Number: DRI6938 Start Date*: 2007-03-21
    Sponsor Name:sanofi-aventis recherche et developpement
    Full Title: A randomized, double-blind, placebo-controlled, parallel group, fixed-dose, 8-week treatment, multi-center trial evaluating the dose effect relationship for efficacy and the safety of 3 oral doses ...
    Medical condition: Aid to smoking cessation in cigarette smokers
    Disease: Version SOC Term Classification Code Term Level
    8.1 10057852 Nicotine dependence LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) SE (Completed) BE (Completed) FR (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2005-005339-83 Sponsor Protocol Number: IPA101985 Start Date*: 2006-05-19
    Sponsor Name:GlaxoSmithKline Research & Development Limited
    Full Title: A two-centre, randomised, double-blind, placebo-controlled, 2-period cross-over study to evaluate the effect of treatment with repeat doses of inhaled GSK256066 on the allergen-induced late asthmat...
    Medical condition: Allergen-induced late asthmatic response
    Disease: Version SOC Term Classification Code Term Level
    8.1 10003567 LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2014-004978-42 Sponsor Protocol Number: ADDICTSTATINE Start Date*: 2015-02-25
    Sponsor Name:CHU DE POITIERS
    Full Title: Pilot randomized double blind, placebo controlled trial of the efficacy of simvastatin for smoking cessation
    Medical condition: Smoking cessation
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004869 10008374 Cessation of smoking LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-005565-20 Sponsor Protocol Number: QMUL111111 Start Date*: 2012-05-02
    Sponsor Name:QUEEN MARY, UNIVERSITY OF LONDON
    Full Title: Comparison of the effects of the electronic cigarette and nicotine inhalator on tobacco withdrawal symptoms over 24 hours of abstinence
    Medical condition: Nicotine withdrawal state
    Disease: Version SOC Term Classification Code Term Level
    14.1 10037175 - Psychiatric disorders 10056484 Nicotine craving LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2018-002829-33 Sponsor Protocol Number: nl_060.32043 Start Date*: 2019-08-28
    Sponsor Name:TNO
    Full Title: Memory reconsolidation: a new treatment approach towards nicotine addiction.
    Medical condition: nicotine addiction
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-000566-40 Sponsor Protocol Number: Protocol H7U-MC-IDAH Start Date*: 2005-08-18
    Sponsor Name:Eli Lilly Company
    Full Title: A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus
    Medical condition: Patients with type 1 diabetes mellitus and many patients with type 2 diabetes mellitus require daily use of insulin for the maintenance of normal glucose homeostasis. At present, insulin can be de...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: View results
    EudraCT Number: 2005-005381-37 Sponsor Protocol Number: H7U-MC-IDAW Start Date*: 2006-06-19
    Sponsor Name:Eli Lilly and Company Ltd
    Full Title: A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients with Type 2 Diabetes Mellitus: Two Populations with Differen...
    Medical condition: Male or female non smoking adults (18-100 years old), diagnosed type 2 Diabetes Mellitus for at least 6 months duration at study entry. Taking at least one or more oral anti-hyperglycemic medicatio...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-001046-13 Sponsor Protocol Number: BUC-58/BIO Start Date*: 2006-04-19
    Sponsor Name:Dr. Falk Pharma GmbH
    Full Title: Pharmacokinetic interaction study between budesonide and metronidazole in healthy volunteers
    Medical condition: Healthy male volunteers
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-004844-59 Sponsor Protocol Number: CAEB071A2117 Start Date*: 2008-01-31
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A two part, randomized, placebo controlled study to evaluate the pharmacokinetics and cardiovascular pharmacodynamics of AEB071 in combination with ritonavir in healthy volunteers
    Medical condition: Healthy volunteers
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2011-001764-21 Sponsor Protocol Number: MANS11 Start Date*: 2011-05-19
    Sponsor Name:Magle AB
    Full Title: The effect of 6 weeks’ use of the Nicachet 4 mg nicotine powder in pouch on the oral mucosa. A short-term smoking cessation and tolerability study.
    Medical condition: Nicotine addiction
    Disease: Version SOC Term Classification Code Term Level
    13.1 10042613 - Surgical and medical procedures 10053325 Smoking cessation therapy PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-000596-16 Sponsor Protocol Number: EETTMK:99/2011 Start Date*: 2012-03-19
    Sponsor Name:Lapland Hospital District/ Lapland Central Hospital
    Full Title: Smoking Cessation of Young Adults in Northern Finland
    Medical condition: Healthy daily smoking young adults aged 18-26 years
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10053325 Smoking cessation therapy PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2006-005383-51 Sponsor Protocol Number: H7U-MC-IDAZ Start Date*: 2007-01-12
    Sponsor Name:Lilly S.A.
    Full Title: A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared with Once-Daily Insulin Glargine in Insulin-Naïve Patients with Type 2 ...
    Medical condition: Type II diabetes
    Disease: Version SOC Term Classification Code Term Level
    14.1 10027433 - Metabolism and nutrition disorders 10067585 Type 2 diabetes mellitus PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2009-016732-12 Sponsor Protocol Number: MAP0004-CL-P203 Start Date*: 2010-01-21
    Sponsor Name:MAP Pharmaceuticals, Inc.
    Full Title: An Open-Label, 2-Period, Crossover Phase 2 Study Comparing the Pharmacokinetics and Tolerability of Dihydroergotamine Mesylate (DHE) Delivered Intravenously (DHE 45) and by Oral Inhalation (MAP0004...
    Medical condition: migraine
    Disease: Version SOC Term Classification Code Term Level
    12.0 10027599 Migraine LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2012-001389-14 Sponsor Protocol Number: CQAW039A2212 Start Date*: 2012-10-19
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A randomized, double-blind, placebo-controlled three-period incomplete cross over study to compare the efficacy of QAW039 alone and in combination with Montelukast in patients with allergic rhinit...
    Medical condition: allergic rhinitis
    Disease: Version SOC Term Classification Code Term Level
    15.0 10038738 - Respiratory, thoracic and mediastinal disorders 10001723 Allergic rhinitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2017-003257-42 Sponsor Protocol Number: ACH-CYT-02 Start Date*: 2017-10-03
    Sponsor Name:Achieve Life Sciences Inc
    Full Title: Repeat-Dose Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers
    Medical condition: Smoking cessation
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-001767-30 Sponsor Protocol Number: A3051070 Start Date*: 2007-07-27
    Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, NY 10017, United States
    Full Title: PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE MULTIPLE-DOSE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF VARENICLINE IN HEALTHY ADOLESCENT SMOKERS
    Medical condition: Smoking cessation
    Disease: Version SOC Term Classification Code Term Level
    9.1 10053325 Smoking cessation therapy LLT
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Not Authorised) GB (Completed)
    Trial results: View results
    EudraCT Number: 2017-001237-65 Sponsor Protocol Number: Start Date*: 2017-06-29
    Sponsor Name:Queen Mary University of London, Joint Research Management Office
    Full Title: Helping Pregnant smokers quit: A multi-centre RCT of electronic cigarettes and nicotine patches
    Medical condition: Tobacco dependence/smoking cessation
    Disease: Version SOC Term Classification Code Term Level
    20.0 10037175 - Psychiatric disorders 10057852 Nicotine dependence PT
    20.0 100000004869 10008374 Cessation of smoking LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: View results
    EudraCT Number: 2018-000048-24 Sponsor Protocol Number: COMB-BO8 Start Date*: 2018-12-28
    Sponsor Name:Sahlgrenska University Hospital/VGR
    Full Title: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER TRIAL ON THE EFFICACY OF VARENICLINE AND BUPROPION, IN COMBINATION AND ALONE, FOR THE TREATMENT OF ALCOHOL USE DISORDER
    Medical condition: Alcohol Use Disorder
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 29 01:49:50 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA